TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
633,791
|
609,905
|
477,861 |
Financial expenses |
5,512
|
5,764
|
4,002 |
Earnings before taxes |
-23,552
|
16,884
|
27,962 |
EBITDA |
8,160
|
44,658
|
48,810 |
Total assets |
637,026
|
546,972
|
455,704 |
Current assets |
345,601
|
279,217
|
197,147 |
Current liabilities |
217,313
|
193,734
|
94,271 |
Equity capital |
402,160
|
330,652
|
227,607 |
- share capital |
10,000
![]() |
10,000
![]() |
10,000 |
Employees (average) |
322
|
312
|
278 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.1%
|
60.5%
|
49.9% |
Turnover per employee |
1,968
|
1,955
|
1,719 |
Profit as a percentage of turnover |
-3.7%
|
2.8%
|
5.9% |
Return on assets (ROA) |
-2.8%
|
4.1%
|
7.0% |
Current ratio |
159.0%
|
144.1%
|
209.1% |
Return on equity (ROE) |
-5.9%
|
5.1%
|
12.3% |
Change turnover |
23,886
|
132,044
|
37,440 |
Change turnover % |
4%
|
28%
|
9% |
Chg. No. of employees |
10
|
34
|
22 |
Chg. No. of employees % |
3%
|
12%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.